The College of Medicine, University of Lagos (CMUL), Idi-Araba, on Wednesday officially commissioned the GP2–CMUL Molecular Laboratory, a state-of-the-art facility aimed at advancing research, training, and capacity building in Parkinson’s disease and related neurological disorders.
The commissioning ceremony, held at the KAARC Building, followed a pre-commissioning seminar earlier in the day at the Old Great Hall of the College.
In his address, the Founding Managing Director of Aligning Science Across Parkinson’s (ASAP), Dr. Ekemini Udofia, highlighted the laboratory’s role in supporting DNA extraction and genetic analysis, emphasizing that international collaboration remains vital for progress in Parkinson’s research.
Prof. Njideka U. Okubadejo, Principal Investigator of the Global Parkinson’s Genetics Programme (GP2) at CMUL, said the laboratory would facilitate molecular and genetic studies while offering training opportunities for both undergraduate and postgraduate students. She explained that the facility is designed for automated DNA extraction and biobanking, and when scaled up further, genetic analysis and sequencing, with plans to expand its genomics and bioinformatics capabilities in the near future.
Okubadejo further noted that the GP2 initiative emphasizes research collaboration, community engagement, training, and capacity development, particularly in under-represented regions.
Representing the Vice-Chancellor of the University of Lagos, Prof. Folashade Ogunshola, and the Provost of CMUL, Prof. Ademola Oremosu, the Deputy Provost, Prof. Daniel Odebiyi, described the commissioning as a significant milestone for the College’s research agenda. He also acknowledged Sir Kensington Adebutu for donating the building housing the laboratory, noting that this contribution would enhance research and innovation at CMUL.
Prof. Olufemi Fasanmade, Dean of the Faculty of Clinical Sciences, said the programme leading to the laboratory’s establishment had already produced several MSc and PhD graduates while increasing the College’s research output in Parkinson’s disease. He added that the laboratory would strengthen local capacity for genetic testing, reducing dependence on overseas facilities.
The GP2–CMUL Molecular Laboratory is set to become a key hub for genomics research, training, and collaboration, contributing to improved understanding and management of Parkinson’s disease across Africa.
